Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$913M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 3 |
Microsoft
MSFT
|
+$369M |
| 4 |
MongoDB
MDB
|
+$345M |
| 5 |
Grab
GRAB
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$867M |
| 2 |
PayPal
PYPL
|
+$519M |
| 3 |
Alibaba
BABA
|
+$393M |
| 4 |
CrowdStrike
CRWD
|
+$360M |
| 5 |
DOCU
DocuSign
DOCU
|
+$335M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.56% |
| 2 | Healthcare | 12.66% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Atossa Therapeutics
ATOS
$23.6M
| $54K | ﹤0.01% |
2,232
-240
| -10% | -$8.78K |
|
3877
Viemed Healthcare
VMD
$355M
| $54K | ﹤0.01% |
10,332
-1,040
| -9% | -$5.8K |
|
|
MTEM
3878
DELISTED
Molecular Templates, Inc.
MTEM
| $54K | ﹤0.01% |
913
-170
| -16% | -$12.7K |
|
|
LITB
3879
LightInTheBox
LITB
$56M
| $53K | ﹤0.01% |
+8,689
| New | +$73.3K |
|
3880
Neurogene
NGNE
$729M
| $53K | ﹤0.01% |
558
-234
| -30% | -$28.5K |
|
|
SVM
3881
Silvercorp Metals
SVM
$2.7B
| $52K | ﹤0.01% |
13,909
-1,660
| -11% | -$6.72K |
|
|
AWH
3882
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $52K | ﹤0.01% |
1,976
-58
| -3% | -$2.2K |
|
|
AIOS
3883
AIOS Tech
AIOS
$38.9M
| $51K | ﹤0.01% |
79
+7
| +10% | +$12.4K |
|
3884
TherapeuticsMD
TXMD
$24M
| $51K | ﹤0.01% |
2,828
-860
| -23% | -$25.8K |
|
|
SURF
3885
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $51K | ﹤0.01% |
10,607
-10,970
| -51% | -$70.8K |
|
3886
CorMedix
CRMD
$591M
| $50K | ﹤0.01% |
10,903
-1,161
| -10% | -$5.76K |
|
3887
Citius Pharmaceuticals
CTXR
$18.6M
| $49K | ﹤0.01% |
1,280
-903
| -41% | -$41K |
|
3888
Dianthus Therapeutics
DNTH
$6.25B
| $49K | ﹤0.01% |
694
-116
| -14% | -$11.7K |
|
|
PPTA
3889
Perpetua Resources
PPTA
$3.11B
| $48K | ﹤0.01% |
+10,073
| New | +$48.8K |
|
3890
Wave Life Sciences
WVE
$1.2B
| $47K | ﹤0.01% |
15,040
-511
| -3% | -$2.12K |
|
|
ADVM
3891
DELISTED
Adverum Biotechnologies
ADVM
| $46K | ﹤0.01% |
2,610
-1,155
| -31% | -$23.1K |
|
3892
Eterna Therapeutics
ERNA
$5.28M
| $46K | ﹤0.01% |
1
-1
| -50% | -$54.4K |
|
|
IMDX
3893
Insight Molecular Diagnostics
IMDX
$154M
| $46K | ﹤0.01% |
1,070
-24
| -2% | -$1.38K |
|
3894
VirnetX Holding Corp
VHC
$60.1M
| $46K | ﹤0.01% |
894
-390
| -30% | -$27.1K |
|
3895
CN Energy Group
CNEY
$5.22M
| $45K | ﹤0.01% |
21
+2
| +11% | +$7.67K |
|
|
TECX
3896
Tectonic Therapeutic
TECX
$639M
| $44K | ﹤0.01% |
949
-620
| -40% | -$35.6K |
|
|
NBEV
3897
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $44K | ﹤0.01% |
42,701
-2,469
| -5% | -$3.26K |
|
3898
Abits Group
ABTS
$3.73M
| $43K | ﹤0.01% |
994
+90
| +10% | +$7.27K |
|
|
EMWP
3899
DELISTED
Eros Media World PLC
EMWP
| $43K | ﹤0.01% |
9,139
-820
| -8% | -$9.37K |
|
3900
Outlook Therapeutics
OTLK
$215M
| $42K | ﹤0.01% |
1,537
-30
| -2% | -$1.07K |
|
Similar funds
Invesco's Q4 2021 Portfolio in Review
As of Q4 2021, Invesco held 4,196 positions worth $415B, up 5.1% from $395B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Invesco's Q4 2021 filing shows 190 new, 1,645 increased, 2,044 reduced and 170 closed positions. Its largest new stake was Grab: 44,484,753 shares worth $317M. The largest sale was Meta Platforms (Facebook), an estimated $867M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2021 buy was Grab: 44,484,753 shares worth $317M.
- Invesco added most to Apple in Q4 2021, an estimated $913M increase.
- Invesco's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $867M.
- Invesco fully exited Kansas City Southern in Q4 2021, selling an estimated $110M.
- Invesco's ten largest holdings make up 12% of its $415B portfolio in Q4 2021.
- Invesco opened 190 new positions and closed 170 in Q4 2021.
- Invesco's portfolio value rose 5.1% quarter-over-quarter to $415B.
Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.